New Zealand markets closed

Galectin Therapeutics Inc. (GALT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2300+0.0900 (+2.87%)
At close: 04:00PM EDT
3.2700 +0.04 (+1.24%)
After hours: 04:56PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
25,660
18,592
39,648
27,142
Total cash
25,660
18,592
39,648
27,142
Other current assets
2,050
1,960
2,172
2,323
Total current assets
27,710
20,552
41,820
29,465
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
74
74
74
74
Accumulated depreciation
-74
-74
-74
-74
Net property, plant and equipment
0
0
0
0
Other long-term assets
490
733
7
135
Total non-current assets
490
733
7
135
Total assets
28,200
21,285
41,827
29,600
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
6,431
3,890
1,805
1,292
Accrued liabilities
8,007
8,045
6,427
3,209
Total current liabilities
15,676
13,012
9,033
5,399
Non-current liabilities
Long-term debt
71,741
39,828
29,048
-
Other long-term liabilities
20
66
-
8
Total non-current liabilities
72,765
40,467
30,178
8
Total liabilities
88,441
53,479
39,211
5,407
Stockholders' equity
Common stock
2,284
2,292
2,309
2,306
Retained earnings
-354,372
-309,567
-270,694
-239,996
Total stockholders' equity
-60,241
-32,194
2,616
24,193
Total liabilities and stockholders' equity
28,200
21,285
41,827
29,600